Orphanet is the European portal dedicated to information on rare
diseases and orphan drugs for patients and their families, health
professionals and researchers, support groups and industry. Its aim is
to contribute to the improvement of the diagnosis, care and treatment of
patients with rare diseases. Orphanet provides an encyclopaedia of rare
diseases, a directory of services in Europe including specialised
clinics, clinical laboratories, research projects, registries, clinical
trials and support groups concerning rare diseases and publishes an
on-line newsletter. Orphanet is run by a consortium of European
partners. It is managed by INSERM and funded by INSERM, the French
Ministry of Health and the European Commission (DG Public Health).
Do you realize that you can now publish in journals published by BioMed Central without directly paying any article-processing charges? Payment of your article-processing charges is covered by Orphanet's Prepay Membership. Read more information about publishing your articles with us.
Work published with BioMed Central, Chemistry Central and SpringerOpen by researchers at Orphanet